[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354421-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354421-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","revisiting-the-immunological-landscape-of-locoregional-therapies-for-gastrointestinal-cancers-a-shift-toward-interventional-immunooncology","Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers - A Shift Toward Interventional ImmunoOncology","","Locoregional therapies have become central tools in treating gastrointestinal cancers, offering minimally invasive options with curative potential. Beyond direct cytotoxicity, these interventions can reshape the tumour microenvironment by triggering immunogenic cell death and initiating local and systemic immune responses, including abscopal effects. The review examines how such immunomodulatory properties can position locoregional treatments as an ideal platform for intratumoural immunotherapy within interventional immuno-oncology.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/revisiting-the-immunological-landscape-of-locoregional-therapies-for-gastrointestinal-cancers-a-shift-toward-interventional-immunooncology/354421/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/revisiting-the-immunological-landscape-of-locoregional-therapies-for-gastrointestinal-cancers-a-shift-toward-interventional-immunooncology/354421.png","ImageObject",300,407,{"name":42,"@type":43},"Blitz","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What immunological effects do locoregional therapies have in gastrointestinal cancers?","Question",{"text":63,"@type":64},"Locoregional therapies can remodel the tumour microenvironment by inducing immunogenic cell death and driving local and systemic immune responses, including abscopal effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does this review describe the role of locoregional therapies in intratumoural immunotherapy?",{"text":68,"@type":64},"It argues that immunomodulatory properties may support locoregional therapies as a platform for intratumoural immunotherapy, strengthening targeted immune activation within the tumour site.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is the abscopal effect important in this context?",{"text":72,"@type":64},"The abscopal effect links the local immune response after tumour intervention to potential destruction of micrometastases and systemic anti-tumour activity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354421,1790497385,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},24464137899374,"https://us-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Current Oncology Reports (2026) 28:71  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1912-026-01807-1  \nREVIEW  \nRevisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional ImmunoOncology  \nAugustin Suffisseau1,2 · Johanne Seguin1 · Katia Lemdani1 · Sarah Diakhaby1 · Claude Capron4,5 · Mostafa El Hajjam3 · Fabrice Ruiz6,7 · Frederique Peschaud2,5 · Nathalie Mignet1 · Robert Malafosse2,6  \nReceived: 6 December 2025 / Accepted: 26 June 2026 © The Author(s) 2026  \nAbstract  \nPurpose of Review Locoregional therapies have emerged as key components in the therapeutic arsenal against gastrointestinal cancers, offering minimally invasive options with curative potential. Beyond their direct cytotoxic effects, these interventions can remodel the tumour microenvironment by inducing immunogenic cell death and initiating local and systemic immune responses, including abscopal effects. This review aims to examine how these immunomodulatory properties may support locoregional therapies as an ideal platform for intratumoural immunotherapy, positioning their combination at the core of the evolving field of interventional immuno-oncology.  \nRecent Findings Recent studies demonstrate that locoregional therapies can induce immune responses through modulation of the tumour microenvironment, creating conditions that may be exploited by intratumoural immunotherapy. This review provides a comprehensive overview of current locoregional modalities, including thermal and non-thermal ablative techniques, transarterial therapies, and minimally invasive radiation methods, detailing their mechanisms of action, clinical applications, and immune-related effects. Special attention is given to emerging evidence supporting the combination of these approaches with intratumoural delivery of immunomodulatory agents, to enhance anticancer immune responses. Summary The convergence of locoregional intervention and targeted immunomodulation represents an emerging therapeutic concept in the treatment of gastrointestinal cancers, offering the prospect of personalised, tumour-directed immune activation. This approach holds the potential to extend the benefits of immunotherapy beyond genetically defined subgroups to a broader patient population.  \nKeywords Gastrointestinal cancers · Locoregional ablative treatment · Intratumoural immunotherapy · Tumour microenvironment · Interventional immuno-oncology  \n􀀍 Augustin Suffisseau [augustin.suffisseau@aphp.fr](augustin.suffisseau@aphp.fr)  \n1 Université Paris Cité, CNRS, INSERM, UTCBS, 4 Avenue de l’Observatoire, Paris 75006, France  \n2 Department of Digestive and Oncologic Surgery, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise Pare Hospital, Université Paris-Saclay, 9 Avenue Charles de Gaulle, Boulogne-Billancourt 92104, France  \n3 Department of Interventional Radiology, Assistance Publique—Hôpitaux de Paris (AP-HP), Ambroise Pare Hospital, Université Paris-Saclay, 9 Avenue Charles de Gaulle, Boulogne-Billancourt 92104, France  \n4 Immunology Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Ambroise-Pare Hospital, Université ParisSaclay, 9 Avenue Charles de Gaulle, Boulogne-Billancourt 92104, France  \n5 EA4340 BCOH, Paris-Saclay University, Gif sur Yvette 91190, France  \n6 IMISCA Therapeutics, 110 Avenue Pierre Brossolette, Malakoff 92240, France  \n7 ClinSearh, 110 Avenue Pierre Brossolette, Malakoff 92240, France  \nIntroduction  \nGastrointestinal cancers account for a quarter of all new cancer cases, with nearly 5 million new cases each year. They are one of the leading causes of malignancy worldwide [1] . A large majority of patients will develop metastases during the course of their disease, leading to death for most of them. For patients with non-metastatic or oligo-metastatic disease, curative treatment is proposed with good long-term oncological outcomes. Surgical resection is the main curative strategy, but the location and si","cbCaid03yfd8ijeI","https://ap.wps.com/l/cbCaid03yfd8ijeI","pdf",3716372,31,"English","# Abstract\n## Purpose of Review\n## Recent Findings\n## Summary\n# Introduction\n## Epidemiology and current curative strategies\n## Expanding roles of locoregional ablative treatments\n## Tumour microenvironment remodelling and immune mechanisms","[{\"question\":\"What immunological effects do locoregional therapies have in gastrointestinal cancers?\",\"answer\":\"Locoregional therapies can remodel the tumour microenvironment by inducing immunogenic cell death and driving local and systemic immune responses, including abscopal effects.\"},{\"question\":\"How does this review describe the role of locoregional therapies in intratumoural immunotherapy?\",\"answer\":\"It argues that immunomodulatory properties may support locoregional therapies as a platform for intratumoural immunotherapy, strengthening targeted immune activation within the tumour site.\"},{\"question\":\"Why is the abscopal effect important in this context?\",\"answer\":\"The abscopal effect links the local immune response after tumour intervention to potential destruction of micrometastases and systemic anti-tumour activity.\"}]","Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers - A Shift Toward Interventional ImmunoOncology | PDF",1790110558,78,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d10d7336db727b9e405c5c1dce3707d.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b7d78d50ac21c73b4871dc0adb68fd4.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af5fddbdf3183d06fc5d386cdc23e130.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89183490455c7ec5dfbfb6bcb35f2e4f.webp",980,1301]